Emergent BioSolutions Inc (EBS):企業の財務・戦略的SWOT分析

◆英語タイトル:Emergent BioSolutions Inc (EBS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1677
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Emergent BioSolutions Inc (EBS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Emergent BioSolutions Inc (Emergent) is a life sciences company. It develops specialty products targeting chemical, biological, radiological, nuclear and explosives (CBRNE), emerging infectious diseases, travel health, emerging health crises and acute/emergency care. It also offers contract development and manufacturing services. Emergent has a developmental pipeline of candidates targeting dengue and other influenza infections. It offers its specialized products to governments and healthcare providers. The company distributes its products in the US and Canada through its commercial sales forces and third party distributors. Emergent is headquartered in Rockville, Maryland, the US.

Emergent BioSolutions Inc Key Recent Developments

Apr 23,2020 Emergent BioSolutions signs agreement to be U.S. Manufacturing partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19
Apr 23,2020 Johnson & Johnson announces collaboration to expand manufacturing capabilities for its COVID-19 Vaccine Candidate in support of the company’s goal to supply more than one billion vaccine doses globally
Apr 21,2020 Emergent BioSolutions appoints Dr. Karen L. Smith as chief medical officer
Apr 06,2020 Emergent BioSolutions appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Emergent BioSolutions Inc – Key Facts
Emergent BioSolutions Inc – Key Employees
Emergent BioSolutions Inc – Key Employee Biographies
Emergent BioSolutions Inc – Major Products and Services
Emergent BioSolutions Inc – History
Emergent BioSolutions Inc – Company Statement
Emergent BioSolutions Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Emergent BioSolutions Inc – Business Description
Emergent BioSolutions Inc – Corporate Strategy
Emergent BioSolutions Inc – SWOT Analysis
SWOT Analysis – Overview
Emergent BioSolutions Inc – Strengths
Emergent BioSolutions Inc – Weaknesses
Emergent BioSolutions Inc – Opportunities
Emergent BioSolutions Inc – Threats
Emergent BioSolutions Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Emergent BioSolutions Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2020: Emergent BioSolutions signs agreement to be U.S. Manufacturing partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19
Apr 23, 2020: Johnson & Johnson announces collaboration to expand manufacturing capabilities for its COVID-19 Vaccine Candidate in support of the company’s goal to supply more than one billion vaccine doses globally
Apr 21, 2020: Emergent BioSolutions appoints Dr. Karen L. Smith as chief medical officer
Apr 06, 2020: Emergent BioSolutions appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs
Feb 20, 2020: Emergent BioSolutions reports financial results for fourth quarter and full year 2019
Jan 13, 2020: Emergent BioSolutions announces preliminary 2019 financial results and provides 2020 financial forecast
Nov 06, 2019: Emergent BioSolutions reports financial results for third quarter and nine months ended September 30, 2019
May 02, 2019: Emergent BioSolutions reports first quarter 2019 financial results
Feb 21, 2019: Emergent Biosolutions reports fourth quarter and full year 2018 financial results
Feb 12, 2019: Emergent BioSolutions names Seamus Mulligan to its Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Emergent BioSolutions Inc, Key Facts
Emergent BioSolutions Inc, Key Employees
Emergent BioSolutions Inc, Key Employee Biographies
Emergent BioSolutions Inc, Major Products and Services
Emergent BioSolutions Inc, History
Emergent BioSolutions Inc, Other Locations
Emergent BioSolutions Inc, Subsidiaries
Emergent BioSolutions Inc, Joint Venture
Emergent BioSolutions Inc, Key Competitors
Emergent BioSolutions Inc, Ratios based on current share price
Emergent BioSolutions Inc, Annual Ratios
Emergent BioSolutions Inc, Annual Ratios (Cont...1)
Emergent BioSolutions Inc, Annual Ratios (Cont...2)
Emergent BioSolutions Inc, Interim Ratios
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Emergent BioSolutions Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Emergent BioSolutions Inc, Performance Chart (2015 - 2019)
Emergent BioSolutions Inc, Ratio Charts
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Emergent BioSolutions Inc (EBS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsubishi Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Clinigen Group Plc (CLIN)-製薬・医療分野:企業M&A・提携分析
    Summary Clinigen Group plc (Clinigen Group) is a pharmaceutical and services company that provides access to medicines, clinical trials, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines including cardioxane, ethyol, foscavir, savene and vibativ. It o …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • SPX Corp (SPXC):企業の財務・戦略的SWOT分析
    SPX Corp (SPXC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Breathe Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Breathe Technologies Inc (Breathe Technologies) is a home health care service provider that manufactures and develops innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases. The company offers research, development and production of new therape …
  • The Housing Bank for Trade and Finance:企業の戦略・SWOT・財務分析
    The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report Summary The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As:企業の戦略・SWOT・財務分析
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Crossject SA (ALCJ):企業の財務・戦略的SWOT分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Amcor Limited
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Smiths Detection Group Limited:戦略・SWOT・企業財務分析
    Smiths Detection Group Limited - Strategy, SWOT and Corporate Finance Report Summary Smiths Detection Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Canadian Zeolite Corp.:企業の戦略・SWOT・財務情報
    Canadian Zeolite Corp. - Strategy, SWOT and Corporate Finance Report Summary Canadian Zeolite Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Edgemont Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Edgemont Pharmaceuticals LLC (Edgemont) is a pharmaceutical company that develops, acquires, and markets products for the treatment of psychiatric disorders. The company focuses on the development of novel drug formulations and therapies in the field of neuroscience. Its portfolio of product …
  • Definiens AG:医療機器:M&Aディール及び事業提携情報
    Summary Definiens AG (Definiens), a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include cons …
  • CIBC Wealth Management:企業の戦略・SWOT・財務分析
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Humana Inc (HUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Eidgenossische Technische Hochschule Zurich:製薬・医療:M&Aディール及び事業提携情報
    Summary Eidgenossische Technische Hochschule Zurich (ETH Zurich) is an educational service provider that offers studies in technology and the natural sciences. The university offers scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architectur …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆